A new platform, named Virtual Synthon Hierarchical Enumeration Screening, has been developed by researchers to efficiently discover drugs.
List view / Grid view
GlaxoSmithKline (GSK) and the University of Oxford will collaborate to investigate diseases using technologies such as functional genomics and machine learning.
Scientists used a CRISPR-based screen to find that inhibiting MTHFD2 reduces disease severity in inflammatory disease models.
Researchers have developed cytochalasin B-induced membrane vesicles which they suggest could be a new form of cell-free therapy in regenerative medicine.
Researchers have discovered a protein that is required for T cell biological processes; they have also demonstrated the mechanism behind the protein.
Researchers have imaged an inflammation-related protein receptor on cell membranes which could inform future drug designs to prevent cell death.
Researchers have found 12 genes which cause MS, creating potential for preventative treatment of the condition.
Researchers have identified an innovative and promising therapeutic option to treat multiple sclerosis...
An inhibitor that stops the action of OGG1 signals, could potentially be used as a treatment for life-threatening Acute Respiratory Distress Syndrome...
Researchers in the U.S. have identified that lymphatic vessels in the brain appear to play a crucial role in the development and progression of multiple sclerosis (MS), providing focus for new treatment research.
Long-term use of either cannabis or cannabis-based drugs impairs memory...
Researchers have identified a receptor in the microglial cells that increases their anti-inflammatory potential in order to reduce the damage in MS...
The discovery is a major step toward understanding the mechanisms of myelin production and the potential for treating certain central nervous system diseases...
A new molecular imaging method can monitor the success of gene therapy in all areas of the brain, potentially allowing physicians to more effectively address brain conditions such as Parkinson's disease, Alzheimer's disease and multiple sclerosis.
Researchers at the University of Alberta in Canada have discovered a unique process of brain cell death called pyroptosis that affects the cells that are most vulnerable in multiple sclerosis (MS).